AAsabys Partners
Asabys Partners is a Barcelona-based venture capital firm investing exclusively in human healthcare, spanning biopharma, medtech, diagnostics, digital health and AI-driven health solutions. It backs early- to growth-stage companies in Spain and internationally, taking a hands-on, board-level role in portfolio companies. The firm manages roughly €280M across two funds (an €80M fund I and a €200M fund II closed in 2023) and has invested in around 29 companies including Splice Bio, Ona Therapeutics, Inbrain Neuroelectronics and Peptomyc.
SectorsBiotech, Medtech, Digital health, Diagnostics, Health-tech
VC MapSeries B
portfolio by sector14
Healthtech & Bio14
Team
Josep Ll. Sanfeliu
Co-founder and managing partner
Clara Campàs
Co-founder and managing partner
Sylvain Sachot
Partner
Guillem Masferrer
Partner
Montse Vendrell
Partner
Jose María Fernández
Partner
Emilio Erazo-Fischer
Operating Partner
Portfolio companies 17
Open 14 as list → On map →
AALLOX
led Seed, 2026
AAnaconda Biomed
led Series B, 2019
IiPremom
entered at Seed, 2026
OOna Therapeutics
led Seed, 2019
OOrikine Bio
led Seed, 2023
O
Oriva Therapeutics
led Pre-seed, 2026
QQida
entered at Series B (estimated), 2025
SSpliceBio
entered at Seed, 2020
Ddeepull
led Series B, 2023
QQuibim
led Series A, 2025
IINBRAIN Neuroelectronics
led Series A, 2021
M
Medlumics
led Series E, 2020
NNuage Therapeutics
led Seed, 2023
KKoa Health
entered at Series A, 2020
Exited or sunsetted (3)
A
Amelia Virtual Care
entered at Series B (estimated), 2022
O
Origo Biopharma
led Seed, 2020
P
Psious
per company site